Depression Clinical Trial
Official title:
A Dose-Finding Study of the Tolerability and Efficacy of Maca Root in Patients With Antidepressant-Induced Sexual Dysfunction
The purpose of this study is to determine the dose of Maca Root effective for the treatment of antidepressant-induced sexual dysfunction in patients with DSM-IV defined Major Depressive Disorder. We propose to carry out a dose-finding pilot study to determine the minimum effective dose of Maca Root. We hypothesize that patients who receive Maca Root will experience alleviation of their sexual dysfunction, and this effect will be more pronounced in those who receive higher doses of maca root.
The purpose of this study is to determine whether Maca Root is effective for the treatment of
antidepressant-induced sexual dysfunction, and to further determine whether higher doses of
Maca Root powder would be more effective than lower doses in reducing the symptoms of
antidepressant-induced sexual dysfunction. An additional aim of the study is to document the
safety and tolerability of Maca Root, which could be particularly helpful in treating
antidepressant-induced sexual dysfunction in elderly and cardiac-impaired populations taking
oral nitrates who may not be eligible for treatment with the current oral phosphodiesterase
inhibitors.
Subjects will be randomized into two arms of 10 for this 12-week study. The study will be
double blind with regard to doses received. Ten subjects will receive 1500mg/day of maca for
the 12-week period and the other 10 subjects will receive 3000mg/day of maca per day for the
12-week study period. Patients will be seen every other week. There is no placebo arm.
At the final study visit, week 12, subjects will be evaluated to see if their sexual function
has returned.
After careful review of the literature we have found that there are very few studies that
have evaluated Maca Root in humans. However the one very relevant study completed by Gonzalez
and colleagues looked at doses of 1500 and 3000mg in men and found there were increased
sexual interests on both doses. Thus, since this is a dose-finding study we believe this dose
is an appropriate place to begin.
Hypotheses A:
The response rate will be higher for the high-dose maca group compared to the low-dose group;
and this response will be comparable to the 50-85% reported with sildenafil.
Hypothesis B:
There will be a statistically significant difference in the magnitude of response between the
two testing conditions, as measured by a decrease in baseline sexual dysfunction scores. The
reduction in sexual dysfunction scores will be greater in the high-dose maca group than in
the low-dose maca group.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |